- Difficulty in precisely calculating Scope 3 emissions due to data limitations from suppliers
- High Scope 3 emissions (estimated at 90% of total carbon footprint)
- Water-intensive manufacturing process
SERB Pharmaceuticals
Greenhouse gas emissions & sustainability report data
In its 2023 reporting, SERB Pharmaceuticals disclosed greenhouse gas emissions of 41.4K tCO2e/year. By scope: Scope 1: 4.0K tCO2e/year; Scope 2: 55 tCO2e/year; Scope 3: 37.4K tCO2e/year. Figures are as stated in the company's own report and may use different boundaries, units or methods (for example market-based vs location-based Scope 2), so compare with care.
GHG Emissions
41.4K tCO2e/year
2023
Renewable Energy
42%
of total energy
Water Usage
12.3 megalitres/year
2023
Waste
91.0 tons/year
2023
📊 Emissions by Scope (2023)
| Scope | What it covers | Reported value |
|---|---|---|
| Scope 1 | Direct emissions from sources the company owns or controls (fuel combustion, company vehicles, process and fugitive emissions). | 4.0K tCO2e/year |
| Scope 2 | Indirect emissions from purchased electricity, steam, heat and cooling. | 55 tCO2e/year |
| Scope 3 | Other indirect emissions across the value chain (purchased goods, business travel, use of sold products, etc.). | 37.4K tCO2e/year |
New to scopes? Read Scope 1, 2 and 3 emissions explained and market-based vs location-based Scope 2.
✅ Reported Environmental Achievements
- 3% reduction in total CO2 equivalent emissions per employee
- 42% renewable energy as a percentage of total energy consumption (up from 36% in 2022)
- 41% reduction in fertilizer (urea) use on production farm
- Installation of new water treatment system in Wales manufacturing facility
- Solar panels installed at Wales Manufacturing facility generating 5% of energy needs
🎯 Climate & Sustainability Targets
🔜 Short-term
- 100 participants in employee volunteer program in 2024
🌱 ESG Focus Areas
Patient care via sustainable business practicesEnvironmental sustainabilitySocial responsibilityGovernance and compliance